0OG · 3-{5-[3-ethyl-5-(5-methylfuran-2-yl)-1H-pyrazol-1-yl]-1-[(6-oxo-1,6-dihydropyridin-3-yl)methyl]-1H-benzimidazol-2-yl}-4-hydroxybenzoic acid

Binding sites

0OG in 2 structures; the first of them:

• 4E92 · Crystal Structure of the N-Terminal Domain of HIV-1 Capsid in Complex With Inhibitor BM4 · 0OG A202 · binds VAL27, ALA31, PHE32, SER33, VAL36, ILE37, LEU56, VAL59 and 8 more
• 4E92 · Crystal structure of the N-terminal domain of HIV-1 capsid in complex with inhibitor BM4 · 0OG A202 · binds VAL27, ALA31, PHE32, SER33, VAL36, ILE37, LEU56, VAL59 and 8 more

Residues it binds most

VAL 4, LEU 4, ALA 4, ILE 4, HIS 4, MET 4, PHE 4, SER 4, TYR 4 (residue and the binding sites it lines).

Found with

• 0OE · 4-{2-[5-(3-chlorophenyl)-1H-pyrazol-4-yl]-1-[3-(1H-imidazol-1-yl)propyl]-1H-benzimidazol-5-yl}benzoic acid